Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongluo Qutong is a Traditional Chinese Medicine (TCM) topical preparation, specifically an ointment, developed as a hospital preparation (院内制剂) by the Gansu Province Second People's Hospital. It is primarily indicated for the treatment of pain associated with cervical spondylotic radiculopathy. The formulation is designed to unblock collaterals and resolve stasis to alleviate musculoskeletal and neurological pain. As a hospital-developed preparation, it is used to improve local blood circulation and reduce inflammatory responses around affected nerve roots, thereby mitigating radicular pain symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongluo Qutong.